CLB Speaker Series: Gregg Alton, Gilead on International Drug Access and IP
February 1, 2010 5:00pm - 6:00pm
Gregg Alton, Executive VP of Gilead
Gilead’s International Access Program: Drug Access and IP
Monday, February 1, 5 - 6 p.m.
Room 280B , Stanford Law School – Food will be served
Gregg Alton is the Executive Vice President of Gilead, and formerly General Counsel. In his current role, Mr. Alton is responsible for legal affairs, government affairs, medical affairs, public affairs, and international access activities. He will discuss Gilead's international access program, which promotes access to Gilead therapeutics for HIV/AIDS and leishmaniasis treatment in the developing world. Mr. Alton will discuss IP issues involved, including licensing with Indian generic manufacturers, and the future and sustainability of the model. Dinner will be served.